Abrams Royal Pharamacy

FDA Regulatory Profile

Abrams Royal Pharamacy appears in FDA public data with 2 recalls — including 1 Class I (most serious) —, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-1564-2014, Class II) was initiated on December 19, 2013.

Summary

Total Recalls
2 (1 Class I)
510(k) Clearances
0
Inspections
0
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-1564-2014Class IIAll Unexpired Sterile Drug Products, compounded by Abrams Royal Pharmacy Inc., Dallas, TXDecember 19, 2013
D-1563-2014Class IMINERAL IV Injection, compounded by Abrams Royal Pharmacy, Inc., Dallas, TXDecember 19, 2013